Renato Delascio Lopes

InstitutionBrazilian Clinical Research Institute - São Paulo (SP)
AddressUnited States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 4 Covid-19 publications, with a maximum of 2 publications in July 2020
    All Publications
    Bar chart showing 30 publications over 11 distinct years, with a maximum of 8 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rosa RG, Robinson CC, Veiga VC, Cavalcanti AB, Azevedo LCP, Machado FR, Berwanger O, Avezum Á, Lopes RD, Lisboa TC, Teixeira C, Zampieri FG, Tomazini BM, Kawano-Dourado L, Schneider D, Souza D, Santos RDRMD, Silva SSD, Trott G, Gimenes BDP, Souza AP, Barroso BM, Costa LS, Brognoli LG, Pelliccioli MP, Studier NDS, Schardosim RFC, Haubert TA, Pallaoro VEL, Oliveira DM, Velho PI, Medeiros GS, Gazzana MB, Zavascki AP, Pitrez PM, Oliveira RP, Polanczyk CA, Nasi LA, Hammes LS, Falavigna M. Quality of life and long-term outcomes after hospitalization for COVID-19: Protocol for a prospective cohort study (Coalition VII). Rev Bras Ter Intensiva. 2021 Jan-Mar; 33(1):31-37. PMID: 33886851.
      Citations:    Fields:    Translation:Humans
    2. Tomazini BM, Maia IS, Bueno FR, Silva MVAO, Baldassare FP, Costa ELV, Moura RAB, Honorato MO, Costa AN, Cavalcanti AB, Rosa RG, Avezum Á, Veiga VC, Lopes RD, Lopes RD, Damiani LP, Machado FR, Berwanger O, Azevedo LCP. COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial. Rev Bras Ter Intensiva. 2020 Jul-Sep; 32(3):354-362. PMID: 33053024.
      Citations: 7     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    3. Farias DLC, Prats J, Cavalcanti AB, Rosa RG, Machado FR, Berwanger O, Azevedo LCP, Lopes RD, Lopes RD, Avezum Á, Kawano-Dourado L, Damiani LP, Rojas SSO, Oliveira CZ, Andrade LEC, Sandes AF, Pintão MC, Castro Júnior CG, Scheinberg P, Veiga VC. Rationale and design of the "Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled" trial (TOCIBRAS). Rev Bras Ter Intensiva. 2020 Jul-Sep; 32(3):337-347. PMID: 32965395.
      Citations: 7     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    4. Ramacciotti E, Macedo AS, Biagioni RB, Caffaro RA, Lopes RD, Lopes RD, Guerra JC, Orsi FA, Marques MA, Tafur AJ, Caprini JA, Nicolaides A, Carter CA, Filho CC, Fareed J. Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620936350. PMID: 32649232.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health